Cardiovascular: Pharmacology - Heart failure Flashcards

1
Q

List 7 classes of treatments used in the management of chronic systolic HF. Which of these confer a mortality benefit and reduction in hospitalisations?

A
  1. Diuretics
  2. Aldosterone receptor antagonists*
  3. ACEIs/ARBs
  4. B-blockers*
  5. Cardiac glycosides
  6. Vasodilators
  7. Resynchronisation, cardioversion
  • mortality benefit and reduction in hospitalisations (certain B-blockers only)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List 6 classes of treatments used in the management of acute HF

A
  1. Diuretics
  2. Vasodilators
  3. B-agonists
  4. Bipyridines
  5. Natriuretic peptide
  6. LVAD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the effect of B-agonists in acute vs chronic HF?

A

Used in treatment of acute HF but reduce survival in chronic HF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What’s the most common cause of HF?

A

CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the three types of HF? Describe each briefly

A
  1. Systolic failure: decreased contractility, HFrEF
  2. Diastolic failure: stiffening and decreased relaxation leading to reduced filling and reduced SV/CO, often HFpEF, more common with increasing age and in women
  3. High-output failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List 4 causes of high-output HF

A
  1. Hyperthyroidism
  2. Anaemia
  3. Beriberi
  4. AV shunts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are four main pathophysiological features of HF? What causes each

A
  1. Increased preload: due to increased Na+/H2O retention, venous tone
  2. Increased afterload: due to increased TPR
  3. Reduce contractility: due to remodelling, cell apoptosis
  4. Increased HR: due to B-adrenergic stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the effects of tachycardia in HF?

A

Reduced filling time and coronary blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the pathophysiology of HF

A
  1. Reduced CO results in reduced carotid sinus firing and reduced renal blood flow
  2. Reduced carotid sinus firing causes increased sympathetic discharge: increased contractility, HR and preload
  3. Reduced renal blood flow activates RAAS: angiotensin II increases afterload and further increases sympathetic discharge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the effect of HF on the baroreceptor reflex?

A

Baroreceptor reflex is reset with lower sensitivity to arterial pressure
Decreased stimulation of vasomotor centre increases sympathetic outflow and decreases parasympathetic outflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What class of drug is digitalis/digoxin?

A

Cardiac glycoside

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the pharmacokinetics of digitalis in terms of its chemical structure and ADME

A

Chemical structure: steroid nucleus, lacks easily ionisable group so solubility is not pH-dependent
Absorption: bioavailability 65-80%
Distribution: widely distributed (including CNS) with 20-30% protein binding
Metabolism: 2/3 excreted unchanged by kidneys, t1/2 = 36-40hrs with normal renal function
Elimination: proportional to CrCl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List four drugs which inhibit excretion of digitalis

A

Amiodarone
Verapamil
Quinidine
Spironolactone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the mechanism of action of digitalis?

A

Inhibits Na+/K+ ATPase
Causes increased intracellular Na+, which produces decrease Ca2+ efflux via Na+/Ca2+ antiport
Increased cytosolic Ca2+ increases contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the effects of digitalis on intracellular K+

A

Initially: increased K+ conductance due to increased Ca2+ causes reduced action potential duration
At higher doses: decreased K+ due to Na+/K+/ATPase pump inhibition causes resting membrane potential to become less negative, can get delayed after-depolarisations which cause ectopics if they reach thresholds -> further increase in dose produces tachyarrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the autonomic effects of digitalis

A

Low therapeutic doses increase parasympathetic effects (predominantly in SA and AV nodes as there is less cholinergic innervation in ventricles)
At toxic doses increases sympathetic outflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the three cardiac effects of digitalis?

A
  1. Positive inotropy
  2. Negative chronotropy (decreased SA node firing and conduction velocity)
  3. Negative dromotropy (increased AV block)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are two extra-cardiac effects of digitalis?

A

GI: increased motility (N+V, diarrohoea), anorexia
CNS: vagal and chemoreceptor trigger zone stimulation, disorientation, hallucination, visual disturbance

19
Q

What is the effect of K+, Ca2+ and Mg2+ on risk of digoxin toxicity?

A

Decreased K+, decreased Mg2+ and increased Ca2+ all increase digoxin toxicity

20
Q

What arrhythmias can be induced by digoxin?

A

AV junctional rhythm
PVCs
Bigeminy
VT
2nd degree AVB

21
Q

How is digoxin toxicity treated?

A

Digibind (sheep Ab)

22
Q

What is the clinical application for digoxin?

A

Used in patients with HF and AF

23
Q

What is the mechanism of action of bipyridines?

A

Inhibits PDE-3
Increased contractility by increased Ca2+ influx during action potential
Also vasodilates

24
Q

Give an example of a bipyridine

A

Milrinone

25
Q

Milrinone half-life

A

3-6hrs

26
Q

Describe the excretion of milrinone

A

10-40% excreted in urine

27
Q

Give an example of a B-agonist used in the management of acute HF

A

Dobutamine

28
Q

What is the mechanism of action of dobutamine?

A

Selective B1-agonist
Increases CO, decreases ventricular filling pressure
May cause tachycardia and increased O2 demand

29
Q

What are the clinical applications of dobutamine?

A

Acute HF
HF with HTN

30
Q

What is the mechanism of action of aldosterone receptor antagonists in the management of HF?

A

Reduces preload by reducing Na+/H2O retention
Also decreases afterload by reducing BP in setting of HF with HTN

31
Q

What is the mechanism of action of ACEIs/ARBs in the management of HF?

A

Reduces afterload by reducing TPR
Reduces preload by reducing Na+/H2O retention
Reduces cardiac and vessel remodelling

32
Q

When should ACEIs/ARBs be used first-line in the management of HTN?

A

In the setting of LV dysfunction without oedema

33
Q

What is the mechanism of action of vasodilators (e.g. nitrates, hydralazine) in the management of HF?

A

Reduced preload by venodilation (e.g. nitrates)
Reduced afterload by arteriolar dilation (e.g. hydralazine)

34
Q

List 4 B-blockers which confer a mortality benefit in HF

A
  1. Bisoprolol
  2. Carvedilol
  3. Metoprolol
  4. Nebivolol
35
Q

What is the mechanism of action of B-blockers in the management of HF?

A

Up-regulation of B-receptors
Attenuation of effects of increased catecholamines (including apoptosis)
Decreased remodelling by inhibition of mitogenic activity of catecholamines
Decreased HR

36
Q

Outline the AHA stages of CHF

A

A: no symptoms, risk factors present
B: symptoms with severe exercise
C: symptoms with marked or mild exercise
D: severe symptoms at rest

37
Q

Outline the NYHA classes of CHF

A

Prefailure: no symptoms, risk factors present
I: symptoms with severe exercise
II: symptoms with marked exercise
III: symptoms with mild exercise
IV: severe symptoms at rest

38
Q

Outline the management of CHF as per the AHA/NYHA stages

A

A/prefailure: treat risk factors (obesity, HTN, DM, hyperlipidaemia)
B/I: ACEI/ARB, B-blocker, diuretic
C/II/III: add aldosterone antagonist, digoxin; CRT, ARNI (angiotensin receptor/neprilysin inhibitor), hydralazine/nitrate
D/IV: transplant, LVAD

39
Q

List 7 classes of anti-anginals. Which can be used to treat variant angina caused by coronary vasospasm?

A
  1. Nitrates*
  2. Nicorandil
  3. CCBs*
  4. B-blockers
  5. Perhexiline
  6. Ivabradine
  7. Allopurinol
  • used in variant angina
40
Q

What is the mechanism of action of nicorandil as an anti-anginal?

A

K+ channel activator
Vasodilatory in normal coronaries
Likely decreases preload and afterload

41
Q

What is the mechanism of action of perhexiline as an anti-anginal?

A

Inhibits mitochondrial enzyme to increase ATP and improve myocardial efficiency

42
Q

What is the mechanism of action of ivabradine as an anti-anginal?

A

Inhibits If Na+ channel
Decreases HR

43
Q

What is the mechanism of action of allopurinol as an anti-anginal?

A

XO inhibitor
Appears to cause increased vasodilation